January 26th, 2010 Blog Citations
1 Harnessing Science: Advancing Care by Accelerating the Rate of Cancer Clinical Trial Participation Hearing before the Committee on Government Reform House of Representatives One Hundred Eight Congress Second Session May 13, 2004 Serial No. 108-189 Retrieved 2007 from GPO Access Web site: http://www.gpoaccess.gov/congress/index.html; http://oversight.house.gov
2 Sateren, W. B., et al. (2002). How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. Journal of Clinical Oncology, 20, 2109-2117.
Christian, M. C., & Trimble, E. L. (2003). Increasing participation of physicians and patients from
underrepresented racial and ethnic groups in National Cancer Institute-sponsored clinical trials. Cancer Epidemiology Biomarkers & Prevention, 12, 277s-283s.; Cancer clinical trials: A resource guide for outreach, education, and advocacy. Retrieved 2006 from National Cancer Institute Web site: www.cancer.gov/clinicaltrials/resources/outreach-education-advocacy; Digest Page: Boosting Cancer Trial Participation. Retrieved 2006 from National Institutes of Health, National Cancer Institute Web site: http://cancer.gov/clinicaltrials/digestpage/boosting-trial-participation
3 Brawley, O. The study of accrual to clinical trials: Can we learn from studying who enters our studies? Journal of Clinical Oncology, 2004. 22(11), 2039-2040.
4 Murthy VH, Krumholz HM, Gross CP Participation in cancer clinical trials: race-, sex-, and age-based disparities.; JAMA. 2004 Jun 9;291(22):2720-6.
Stewart et al Participation in Surgical Oncology Clinical Trials:Gender-, Race/Ethnicity-, and Age-based Disparities Annals of Surgical Oncology 14(12):3328-3334
5 Dilts, D. (2008). (Vanderbilt University) Personal correspondence based on unpublished data of CALGB and ECOG; February 2, 2008.